BNP/CALL/MERCK & CO./110/0.1/20.06.25 Share Price

Warrant

DE000PN7EMM2

Market Closed - Deutsche Boerse AG 01:20:22 06/07/2024 am IST
2.16 EUR +3.85% Intraday chart for BNP/CALL/MERCK & CO./110/0.1/20.06.25
Current month-2.26%
1 month-10.74%
Date Price Change
05/24/05 2.16 +3.85%
04/24/04 2.08 -1.42%
03/24/03 2.11 -7.86%
02/24/02 2.29 -2.14%
01/24/01 2.34 +5.88%

Delayed Quote Deutsche Boerse AG

Last update July 06, 2024 at 01:20 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7EMM
ISINDE000PN7EMM2
Date issued 17/08/2023
Strike 110 $
Maturity 20/06/2025 (348 Days)
Parity 10 : 1
Emission price 1.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.84
Lowest since issue 0.72
Delta0.77x
Omega 4.149
Premium5.51x
Gearing5.4x
Moneyness 1.150
Difference Strike -16.45 $
Difference Strike %-14.95%
Spread 0.02
Spread %0.92%
Intrinsic value 1.518

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus